Definitive Contract 75N93021C00017

Award Date 4/1/21
Potential Completion Date 1/14/27
Potential Value $79M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Atlanta, GA 30322, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed

Emory University, a private research institution in Atlanta, Georgia, was awarded a $79,299,221 Definitive Contract from the National Institute of Allergy and Infectious Diseases (NIAID) to serve as a Center of Excellence for Influenza Research and Response (CEIRR). The contract has a period of performance through January 14, 2027 and does not have a set-aside designation. Emory is serving as the prime contractor on this award, with several universities - including the University of Kentucky, University of Illinois, University of Wisconsin, Pennsylvania State University, and others - participating as subcontractors. The CEIRR contract is part of NIAID's broader effort to establish a collaborative network focused on advancing the understanding and development of influenza control measures. Emory will leverage its expertise in infectious disease research to contribute to this mission.

Generated 3/14/25, 9:43 AM